A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas Meeting Abstract
| Authors: | Kelly, R. J.; Abrams, T. A.; Catenacci, D. V. T.; Wainberg, Z. A.; Lin, B. S. L.; Enstrom, A.; Whiting, C. C.; Wason, P.; Murphy, A.; Brockstedt, D. G.; Moon, A.; Walling, J.; Lai, R.; Ku, G. Y. |
| Abstract Title: | A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas |
| Meeting Title: | 2018 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2018 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000436174100192 |
| DOI: | 10.1200/JCO.2018.36.4_suppl.TPS200 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS200 -- Source: Wos |
